on this page
Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with teduglutide under the National Health Act 1953, section 100 for patients with type III short bowel syndrome (SBS) with intestinal failure.
Patients must be eligible for the PBS and meet the relevant restriction criteria.
The Schedule of Pharmaceutical Benefits on the PBS website outlines the restrictions for prescribing teduglutide.
Section 100 arrangements
Teduglutide
This item is only PBS-subsidised for day admitted patients, non-admitted patients, or patients on discharge who are attending either:
- an approved private hospital
- a public participating hospital
- a public hospital.
You must include the hospital name and provider number on the authority application form. This item isn’t PBS-subsidised for hospital in-patients.
Treatment specifics
To be eligible for PBS-subsidised treatment with teduglutide, patients must be treated by a gastroenterologist or by a specialist within a multidisciplinary intestinal rehabilitation unit.
Applications
Applying for initial treatment
Apply for authority approval to prescribe initial PBS-subsidised teduglutide to treat SBS in writing and either:
- upload through Health Professional Online Services (HPOS)
- post to PBS Complex Drugs Programs.
All applications must include the completed:
- authority prescription form or forms
- short bowel syndrome - initial PBS authority application form
- relevant attachments.
Applying for recommencing treatment
Apply for authority approval to recommence PBS-subsidised teduglutide to treat SBS in writing and either:
- upload through HPOS
- post to PBS Complex Drugs Programs.
All applications must include the completed:
- authority prescription form or forms
- short bowel syndrome - recommencing PBS authority application form
- relevant attachments.
First continuing treatment
Apply for authority approval for first continuing PBS-subsidised teduglutide treatment of SBS in writing and either:
- upload through HPOS
- post to PBS Complex Drugs Programs.
All applications must include the completed:
- authority prescription form or forms
- short bowel syndrome - first line continuing PBS authority application form
- relevant attachments.
Subsequent continuing treatment
Apply for authority approval for subsequent continuing PBS-subsidised teduglutide for treatment of SBS in writing and either:
- upload through HPOS
- post to PBS Complex Drugs Programs.
All applications must include the completed:
- authority prescription form or forms
- short bowel syndrome - subsequent continuing PBS authority application form
- relevant attachments.
Further information
Call the PBS Complex Drugs Programs enquiry line for more information.